Dentsply Sirona Inc (XRAY) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges

By Yahoo! Finance | Nov 8, 2024 at 02:17 AM EST

BYTE sales were suspended for regulatory review and strategic assessment. The company aims to reduce costs due to high expenses and is focusing on growth in the implant business by enhancing sales efforts. Investments are made to stimulate growth, and the launch of Primescan 2 has been successful.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.